Cargando…
The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
Aberrant promoter methylation of RUNX3 has been reported in several tumors including human breast cancer (BC). However, the association between RUNX3 hypermethylation and incidence of BC remains elusive. In this study, a detailed literature search was performed in Medline and Google Scholar for rela...
Autores principales: | Song, Xiao-yun, Li, Bo-yan, Zhou, En-xiang, Wu, Feng-xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008647/ https://www.ncbi.nlm.nih.gov/pubmed/27616890 http://dx.doi.org/10.2147/OTT.S77828 |
Ejemplares similares
-
Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC
por: Xue, Ruilin, et al.
Publicado: (2014) -
Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis
por: Mu, Wei-Ping, et al.
Publicado: (2014) -
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
por: Wei, Bing, et al.
Publicado: (2016) -
Clinicopathological significance and potential drug target of RUNX3 in breast cancer
por: Yu, Ying-Ying, et al.
Publicado: (2014) -
The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)